journal article·2018-11-12Open access

The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line

Mahnoosh Abbaszade Dibavar, Masoud Soleimani, Amir Atashi, Neda Rassaei, Shahin Amiri

Abstract

Acute Promyelocytic Leukemia is one of the most prevalent forms of leukemia which has been treated with arsenic trioxide (ATO) and/or all-trans retinoic acid (ATRA). Although, ATRA and ATO are broadly accessible and administrated, some adverse side effects have been reported recently. Nowadays, microvesicles (MVs) are considered as a potential therapeutic agent. Their capacity to alter the behavior of the cells is one of the most controversial issues. In this study, we investigated apoptotic effects of MVs derived from human bone marrow mesenchymal stem cells (hBM-MSCs) in combination with ATO on NB4 cell line. MVs were isolated by ultra-centrifugation. After 7 days, MTT assay, Annexin-V-fluorescein staining assay and RT-qPCR for BCL-2, KI67, BAX genes expression were performed. The results showed lower cell viability rate, higher apoptosis ratio, higher BAX gene, and lower KI67 and BCL-2 genes' expression in cells exposed to MVs in combination with ATO compared to cells treated with each agent alone and non-treated control. We showed that MVs in combination with ATO had more apoptotic effect on NB4 cell line than each agent alone. MVs in combination with ATO in APL treatment might play an effective therapeutic role with fewer adverse side effects compared to any other agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Retinoids in leukemia and cellular processes · Bone and Joint Diseases · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University

Department of Hemetology, Faculty of Medical Sciences, Hematology and cell therapy, Tarbiat Modares University

Stem Cell and Tissue Engineering Research Center, Shahroud University of Medical Sciences

Department of Medical Biotechnology, Cellular and Molecular Research Centre, Qazvin University of Medical Sciences

References (38)

Show source-provided references
1. 10.5045/br.2013.48.4.25010.5045/br.2013.48.4.250 ↗
2. 10.1111/joim.1237610.1111/joim.12376 ↗
3. 10.1111/jcmm.1255010.1111/jcmm.12550 ↗
4. 10.1093/annonc/mdj01910.1093/annonc/mdj019 ↗
5. 10.1177/204062071141077310.1177/2040620711410773 ↗
6. 10.1159/00007756010.1159/000077560 ↗
7. 10.1016/j.leukres.2014.05.01910.1016/j.leukres.2014.05.019 ↗
8. 10.1002/jcb.2483810.1002/jcb.24838 ↗
9. 10.5045/kjh.2012.47.2.10510.5045/kjh.2012.47.2.105 ↗
10. 10.1038/leu.2016.6910.1038/leu.2016.69 ↗
11. 10.1007/s12032-009-9294-910.1007/s12032-009-9294-9 ↗
12. 10.1007/s11064-014-1288-010.1007/s11064-014-1288-0 ↗
13. 10.3390/ijms1807145010.3390/ijms18071450 ↗
14. 10.1016/j.bbi.2016.11.01110.1016/j.bbi.2016.11.011 ↗
15. 10.1089/scd.2012.030410.1089/scd.2012.0304 ↗
16. Tetta C, Consiglio AL, Bruno S, et al. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J. 2012;2:212.
17. Alimoghaddam K. A review of arsenic trioxide and acute promyelocytic leukemia. Int J Hematol Oncol Stem Cell Res. 2014;8:44
18. 10.1200/JCO.2010.32.106710.1200/JCO.2010.32.1067 ↗
19. 10.1007/s11427-010-0004-910.1007/s11427-010-0004-9 ↗
20. 10.1007/s12032-011-9946-410.1007/s12032-011-9946-4 ↗
21. 10.1007/s12032-010-9430-610.1007/s12032-010-9430-6 ↗
22. 10.1016/j.pathol.2016.11.00610.1016/j.pathol.2016.11.006 ↗
23. 10.1016/j.preteyeres.2017.01.00210.1016/j.preteyeres.2017.01.002 ↗
24. Chen F, Zhou K, Zhang L, et al. Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways. Stem Cells Dev. 2013; 22:1955–1967.
25. 10.1182/blood.V94.10.3315.422k16_3315_332410.1182/blood.V94.10.3315.422k16_3315_3324 ↗
26. 10.1007/s11684-017-0514-y10.1007/s11684-017-0514-y ↗
27. 10.1186/s13287-018-0791-710.1186/s13287-018-0791-7 ↗
28. 10.1371/journal.pone.004284010.1371/journal.pone.0042840 ↗
29. 10.1093/ndt/gfs16810.1093/ndt/gfs168 ↗
30. 10.1007/s00018-011-0689-310.1007/s00018-011-0689-3 ↗
31. 10.1038/nri256710.1038/nri2567 ↗
32. 10.1182/blood-2008-08-17409410.1182/blood-2008-08-174094 ↗
33. 10.1089/scd.2014.009110.1089/scd.2014.0091 ↗
34. 10.1371/journal.pone.000714010.1371/journal.pone.0007140 ↗
35. 10.1038/sj.leu.240413210.1038/sj.leu.2404132 ↗
36. 10.1371/journal.pone.001180310.1371/journal.pone.0011803 ↗
37. 10.1681/ASN.200807079810.1681/ASN.2008070798 ↗
38. 10.1093/carcin/bgx04510.1093/carcin/bgx045 ↗